One reason for the presence of a certain number of prostate cancers with negative results from PSMA PET/CT and positive results from FDG PET/CT appears to involve neuroendocrine de-differentiation resulting in the downregulation of PSMA expression and the absence of radiotracer uptake [69]. The gene discussed is FOLH1; the disease is prostate carcinoma.